Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Dana M Lewis"'
Autor:
Jasmine Schipp, Christel Hendrieckx, Katarina Braune, Christine Knoll, Shane O’Donnell, Hanne Ballhausen, Bryan Cleal, Mandy Wäldchen, Dana M Lewis, Katarzyna A Gajewska, Timothy C Skinner, Jane Speight
Publikováno v:
Journal of Medical Internet Research, Vol 25, p e44002 (2023)
BackgroundEmerging research suggests that open-source automated insulin delivery (AID) may reduce diabetes burden and improve sleep quality and quality of life (QoL). However, the evidence is mostly qualitative or uses unvalidated, study-specific, si
Externí odkaz:
https://doaj.org/article/408e5e8b78d543c39d38a4a92fbf1ea1
Autor:
Dana M Lewis
Publikováno v:
The Lancet: Digital Health, Vol 5, Iss 9, Pp e548-e549 (2023)
Externí odkaz:
https://doaj.org/article/64ec3494dfe34a0ba17c4701119bc3ed
Autor:
Dana M. Lewis, Nancy T.H. Colchester, David Allen, James A.R. Nicoll, Haider A. Katifi, Andrew S. Duncombe
Publikováno v:
Case Reports in Neurology, Vol 14, Iss 1, Pp 213-222 (2022)
It is well recognized that B-cell clonal disorders such as Waldenstrom’s macroglobulinaemia may affect the central nervous system by direct infiltration of malignant B cells (Bing-Neel syndrome). However, there is no recognition in the current lite
Externí odkaz:
https://doaj.org/article/23fcc1d11ab343938f301f662b201ec5
Autor:
Mercedes J. Burnside, Dana M. Lewis, Hamish R. Crocket, Renee A. Meier, Jonathan A. Williman, Olivia J. Sanders, Craig A. Jefferies, Ann M. Faherty, Ryan G. Paul, Claire S. Lever, Sarah K.J. Price, Carla M. Frewen, Shirley D. Jones, Tim C. Gunn, Christina Lampey, Benjamin J. Wheeler, Martin I. de Bock
Publikováno v:
Diabetes Technology & Therapeutics. 25:250-259
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b662c1b395fa5907fa0f35979fe259b0
https://doi.org/10.1089/dia.2022.0484
https://doi.org/10.1089/dia.2022.0484
Autor:
Arsalan Shahid, Dana M. Lewis
Publikováno v:
Nutrients, Vol 14, Iss 9, p 1906 (2022)
Open-source automated insulin delivery (AID) technologies use the latest continuous glucose monitors (CGM), insulin pumps, and algorithms to automate insulin delivery for effective diabetes management. Early community-wide adoption of open-source AID
Externí odkaz:
https://doaj.org/article/9763822ddc7a4d74a2315312b6d50b3f
Autor:
Mercedes J. Burnside, Dana M. Lewis, Hamish R. Crocket, Renee A. Meier, Jonathan A. Williman, Olivia J. Sanders, Craig A. Jefferies, Ann M. Faherty, Ryan G. Paul, Claire S. Lever, Sarah K.J. Price, Carla M. Frewen, Shirley D. Jones, Tim C. Gunn, Christina Lampey, Benjamin J. Wheeler, Martin I. de Bock
Publikováno v:
New England Journal of Medicine. 387:869-881
Open-source automated insulin delivery (AID) systems are used by many patients with type 1 diabetes. Data are needed on the efficacy and safety of an open-source AID system.In this multicenter, open-label, randomized, controlled trial, we assigned pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da11ba53754e5b211b0fef56ce63774c
https://doi.org/10.1056/nejmoa2203913
https://doi.org/10.1056/nejmoa2203913
Autor:
Dana M. Lewis, Joanne Milo, Jhea Espares, Jessie Lin, Jodie Li, Denise Tang, Heidi Rataj, Eliah Aronoff-Spencer
Publikováno v:
Journal of Diabetes & Metabolic Disorders. 21:791-804
People living with Type 1 diabetes (T1D) are living longer than ever and facing the new "luxury" of the challenges of aging. While research is slowly expanding and addressing T1D physiology with regards to aging, there is little research addressing s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e300f14b46bf4c4e5cc9b44e5b31d5b7
https://doi.org/10.1007/s40200-022-01056-6
https://doi.org/10.1007/s40200-022-01056-6
Autor:
MERCEDES J. BURNSIDE, DANA M. LEWIS, HAMISH CROCKET, RENEE MEIER, JONATHAN WILLIMAN, OLIVIA J. SANDERS, CRAIG A. JEFFERIES, ANN M. FAHERTY, RYAN PAUL, CLAIRE S. LEVER, BENJAMIN J. WHEELER, SHIRLEY JONES, CARLA M. FREWEN, TIM GUNN, CHRISTINA LAMPEY, MARTIN DE BOCK
Publikováno v:
Diabetes. 71
Objective: Open-source automated insulin delivery (AID) pre-dated the availability of commercial systems and is used by thousands of people with T1D despite no regulatory approval. Our objective was to examine efficacy and safety of open-source AID.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2d98dad2d663401b0613ad902893d1dc
https://doi.org/10.2337/db22-286-or
https://doi.org/10.2337/db22-286-or
Publikováno v:
History and Anthropology. :1-28
Once known as America’s ‘Haven of Health’, the city of Excelsior Springs, Missouri, USA was home to an estimated 40 unique mineral spring and well sites. This collection of mineral waters is one of...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c66a2787d85dd31f97073a92868c28ee
https://doi.org/10.1080/02757206.2021.1901286
https://doi.org/10.1080/02757206.2021.1901286
Autor:
Dana M Lewis, Emma Doble
Publikováno v:
BMJ (Clinical research ed.). 375
Historically, patients have always been considered the passive recipients of healthcare. This way of thinking affected everything from how people were cared for in a clinician’s office or hospital bed, to how they participated in clinical trials. I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b3774929a2ef471d6fe68f2dbb69224
https://pubmed.ncbi.nlm.nih.gov/34819302
https://pubmed.ncbi.nlm.nih.gov/34819302